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Article focus
  this study aimed to establish the mini-
mum biofilm eradication concentration of 
acetic acid in the context of debridement 
surgery for periprosthetic joint infection.
Key messages
  the minimum biofilm eradication con-
centration of acetic acid with a ten- or 
20-minute treatment time exceeded its 
safety threshold.
  A clinically acceptable concentration 
(5%) was still found to eliminate 96.1% 
of biofilm-associated methicillin-sensitive 
Staphylococcus aureus (MssA) following 
a 20-minute treatment time.
Strengths and limitations
  this study provides an evaluation of the of 
the biofilm eradication potential of acetic 
acid using a clinically relevant outcome.
  the main limitation of this study was that 
acetic acid was only evaluated against 
MssA biofilms.
Introduction
Periprosthetic joint infection (PJI) following 
joint arthroplasty surgery is one of the most 
feared complications due to its resistance to 
conservative treatment with standard antibi-
otic therapy,1 the implications on patient 
health-related quality of life and function, 
and associated healthcare costs (£20 000 to 
The biofilm eradication activity of 
acetic acid in the management of 
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Objectives
periprosthetic joint infection following joint arthroplasty surgery is one of the most feared 
complications. The key to successful revision surgery for periprosthetic joint infections, 
regardless of treatment strategy, is a thorough deep debridement. In an attempt to limit 
antimicrobial and disinfectant use, there has been increasing interest in the use of acetic acid 
as an adjunct to debridement in the management of periprosthetic joint infections. How-
ever, its effectiveness in the eradication of established biofilms following clinically  relevant 
treatment times has not been established. Using an in vitro biofilm model, this study aimed 
to establish the minimum biofilm eradication concentration (MBec) of acetic acid following 
a clinically relevant treatment time.
Materials and Methods
Using a methicillin-sensitive Staphylococcus aureus (MssA) reference strain and the dissolv-
able bead assay, biofilms were challenged by 0% to 20% acetic acid (pH 4.7) for ten min-
utes, 20 minutes, 180 minutes, and 24 hours.
Results
The MBec of acetic acid was found to be: 15%, 11%, 3.2%, and 0.8% following a ten-minute, 
20-minute, 180-minute, and 24-hour treatment, respectively.
Conclusion
This study found that the MBec of acetic acid following a 10- or 20-minute treatment time 
exceeded its safety threshold, making these concentrations unsuitable as a topical debride-
ment adjunct. However, a clinically acceptable concentration (5%) was still found to elimi-
nate 96.1% of biofilm-associated MssA following a 20-minute treatment time.
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£100  0002,3 per patient).4 National surveillance data in 
the united Kingdom, based on inpatient, readmission 
episodes, and the number of revision procedures per-
formed,5-9 estimate the incidence of PJI to be between 
0.5% and 2%, although this may under-report the true 
value.10 the key to successful revision surgery for PJIs is 
thorough deep debridement.11 In an attempt to rational-
ize antimicrobial and disinfectant use, there has been 
increasing interest in the use of acetic acid as an adjunct 
to debridement in the management of PJI.12,13 other 
commonly used topical adjuvant treatments for PJIs such 
as Betadine (Povidone-iodine), Dakin’s solution (sodium 
hypochlorite) or hydrogen peroxide (H2o2) have been 
shown to be only partially effective in the eradication of 
bacterial biofilms.14
Acetic acid, commonly found in vinegar and pro-
duced by the oxidation of ethanol, has been used in the 
treatment of infection since the time of Hippocrates.15 It 
is a weak organic acid that is active against gram-
positive and -negative organisms.16-19 Previous studies 
have demonstrated its inhibitory and eradication action 
against bacteria in both planktonic and biofilm 
states.18,19 It has also been used in the treatment of ear 
infections,20 burn wounds,21 and catheter-associated 
urinary tract infections.16 It has united states Food and 
Drug Administration approval for the therapeutic use of 
a 0.25% solution in bladder irrigation and a 2% solu-
tion for treating otitis externa.18 A recent study demon-
strated that it had an acceptable safety profile and 
patient tolerance when used as an adjunct to debride-
ment in PJIs.13 the minimum biofilm eradication con-
centration is now widely recognized and is defined as 
the lowest concentration of an antimicrobial that eradi-
cates 99.9% of the colony-forming units (CFu), (i.e. a 
three-log reduction) in a bacterial biofilm, compared 
with growth controls in the same conditions.22 this 
reduction provides a much more robust approximation 
to the expected in vivo effect. the minimum biofilm 
eradication concentration (MBEC) is generally 100- to 
1000-times greater than the minimum inhibitory con-
centration (MIC).23,24 However the effectiveness of ace-
tic acid in the eradication of established biofilms 
following clinically relevant treatment times has not 
been established. using an in vitro biofilm model, this 
study aimed to establish the MBEC of acetic acid follow-
ing the clinically relevant treatment times of 10 and 20 
minutes. the MBEC of acetic acid was also established 
for exposure times of 180 minutes and 24 hours to 
allow comparison with previous investigations using 
alternative in vitro biofilm models.
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Fig. 1
Box plot of biofilm S. aureus CFu/ml detected following a ten-minute exposure to acetic acid. Dashed line represents a 99.9% reduction. solid line represents 
detection limit of assay.
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Materials and Methods
A methicillin-sensitive Staphylococcus aureus (MssA) ref-
erence strain (American type Culture Collection 29213), 
was used, which has been extensively studied in its bio-
film state.25-27 For culture, nutrient broth, with the pH 
adjusted to 7.5 prior to autoclaving, was applied. For 
plating, nutrient was solidified by adding 15 g/l Difco 
agar (Fisher scientific, loughborough, united Kingdom), 
prior to autoclaving. using the dissolvable bead biofilm 
assay, as described by Dall et al,28 sodium alginate beads 
(4% weight/volume, (w/v), Fisher scientific) were incu-
bated in a broth culture at 37°C in an orbital shaking 
incubator, (gallenkamp Weiss technik, loughborough, 
united Kingdom), set at 200 rpm for 24 hours. 
unchallenged control beads were washed twice in sterile 
phosphate buffered saline (PBs) and housed in 2 ml PBs 
for ten minutes, 20 minutes, 180 minutes, or 24 hours, 
under sterile conditions. the remaining beads were 
washed twice in sterile PBs and transferred under sterile 
conditions to treatment wells (Acetic acid 0-20% (pH 
4.7)) at a desired concentration in 2 ml PBs for ten 
 minutes, 20 minutes, 180 minutes, or 24 hours. 
Concentrations from 0% to 20% at 1% intervals were ini-
tially examined for all exposure times. Further rationaliza-
tion was performed if a greater than two-log reduction 
occurred between 1% increments. the beads were 
washed for a third time with 2 ml sterile PBs before being 
dissolved, serially diluted, and plated per the dissolvable 
bead assay protocol.28 Biological replicates were per-
formed in triplicate with three further technical replicates 
for each biological replicate. Data were analyzed using 
sPss statistical software version 22.0 (IBM Corp., Armonk, 
New york). Comparisons between continuous data were 
performed using a univariate analysis of variance.
Results
the control beads were found to have a mean 3.06 × 107 
CFu/ml (95% confidence interval (CI) 2.75 × 107 to 3.36 
× 107) within the biofilms attached to their surface. A 
three-log (99.9%) reduction was achieved by 15%, 11%, 
3.2%, and 0.8% acetic acid following ten minutes, 20 
minutes, 180 minutes, and 24-hour treatment times, 
respectively. Further rationalization of the MBEC was per-
formed at 0.1% intervals, between 0% and 1% for 24-hour 
exposures and between 3% and 4% for 180- minute expo-
sures. A summary of bacterial eradication for each treat-
ment time is shown in Figures 1, 2, 3, and 4. A solution of 
5% acetic acid, with a 20-minute treatment time, was 
found to have eradicated 96.1% (95% CI 69.3 to 123.1) 
of biofilm-associated MSSA, 3% acetic acid was found to 
eradicate 85.9% (95% CI 5.9 to 113.0) of viable bacteria 
(Fig. 2).
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Fig. 2
Box plot of biofilm S. aureus CFu/ml detected following a 20-minute exposure to acetic acid. Dashed line represents a 99.9% reduction. solid line represents 
detection limit of assay.
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Discussion
this study has found that the MBEC of acetic acid, when 
used for clinically-relevant treatment times of ten min-
utes and 20 minutes, were 15% and 11%. Acetic acid is 
considered to be harmless below concentrations of 5%, 
as in vinegar, but in concentrations between 10% and 
30% acetic acid has been found to be corrosive to human 
tissue.18 Acetic acid is known to be mildly corrosive to 
metals such as iron, magnesium, and zinc.29 However, 
for the concentrations and exposure times examined in 
this study, commonly used metals for orthopaedic 
implants and prostheses, such as stainless steel 316 and 
titanium, have been shown to be resistant to the corro-
sive effects of acetic acid in the environmental conditions 
encountered during debridement surgery.30,31
Williams et al13 have reported that a 20-minute soak of 
3% acetic acid was a safe and effective adjunct to surgical 
debridement in the management of PJIs following knee 
arthroplasty. this recommendation was based on 3/8 
planktonic clinical isolates demonstrating zones of inhibi-
tion to 3% acetic acid on disc susceptibility testing and 
0.19% acetic acid inhibiting growth in liquid cultures of 
clinical isolates that is the MIC. However, the MIC is rec-
ognized to be a poor predictor for microbial biofilm erad-
ication, commonly resulting in treatment failure.23,24 In 
our study, the MBEC of acetic acid following a 20-minute 
treatment time was found to exceed the concentration 
considered to be harmless (5%). However, although a 
microbiologically significant reduction of the biofilm 
could not be achieved with a clinically acceptable con-
centration and relevant treatment time, there may still be 
a role for acetic acid. We found that a solution of 5% ace-
tic acid eradicated 96.1% of biofilm-associated MssA and 
even 3% acetic acid eradicated 85.9% of viable bacteria. 
this near two-log reduction in bacterial load may still be 
useful in assisting debridement and the host immune sys-
tem in clearing the remaining infection.
In this study, the 24-hour MBEC of acetic acid previously 
estimated by Bjarnsholt et al18 has been further rationalized. 
using a continuous flow assay, as described by Christiansen 
et al,32 of 72-hour S. aureus biofilms Bjarnsholt et al18 esti-
mated the MBEC of acetic acid with a 24-hour treatment 
time to be between 0.5% and 1%. In our study, we used a 
dissolvable bead biofilm and the MBEC for acetic acid fol-
lowing a 24-hour treatment time was estimated to be 0.8%. 
However, it should be noted that Bjarnsholt et al18 tested 
acetic acid against more mature (72- vs 24-hour) S. aureus 
biofilms. the maturity of biofilms, and more importantly, 
their mass, have both been shown to influence bacterial 
resistance to antimicrobials.33-35
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Fig. 3
Box plot of biofilm S. aureus CFu/ml detected following a 180-minute exposure to acetic acid. Dashed line represents a 99.9% reduction. solid line represents 
detection limit of assay.
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Halstead et al19 estimated the minimum biofilm inhibi-
tory concentration (MBIC) of acetic acid to range from 
<  0.10% to 0.31% against clinical isolates, including 
methicillin- resistant Staphylococcus aureus (MRsA), taken 
from burns wounds using the crystal violet assay.36-38 the 
MRsA isolate had a minimum biofilm inhibitory concen-
tration (MBIC) 0.31%. the MBEC for acetic acid against 
these same clinical isolates was found to range from 
0.10% to 2.5%, with the MBEC against the MRsA isolate 
being 1.25%. In general, Halstead et al19 found that 
gram-negative organisms were more susceptible to ace-
tic acid than gram-positive species. the MBEC was deter-
mined using an indirect count of viable cells using a 
modified version of the Calgary model, as described by 
Ceri et al,25 rather than direct enumeration of viable cells. 
In a study performed by Halstead et al,19 biofilms of clini-
cal isolates were grown on polystyrene pegs for 72 hours, 
as per the Calgary model. After a three-hour treatment 
with acetic acid, the pegs underwent overnight culture in 
broth. optical density of the broth was performed the 
next day to estimate the number of cells that had seeded 
into the broth from the biofilm on the polystyrene peg. 
the indirect method of viable cell enumeration following 
treatment used by Halstead et al19 may explain why the 
MBEC was found to be lower than the concentration 
(3.2%) found in our study. It is possible that not all viable 
cells were liberated from the polystyrene pegs thus over-
estimating the bactericidal effect of acetic acid for a given 
concentration.
Previous studies also have postulated that the antibac-
terial effect of acetic acid was due to the non-dissociated 
form of acetic acid (CH3CooH), rather than dissociated 
protons. Weak acids exist in an equilibrium of ionized and 
non-ionized forms in solution, unlike strong acids such as 
hydrochloric acid, which completely dissociate in solu-
tion into their ionized form. the non-ionized forms of 
weak acids can freely diffuse across hydrophobic phos-
pholipid bacterial membranes.39,40 Cytotoxicity caused 
by weak acids is due to disruption of the proton gradients 
that are necessary for AtP synthesis.17,41 Intracellular ace-
tic acid dissociates to form acetate, which combines with 
periplasmic protons pumped out by the electron trans-
port chain and carries them back across the membrane 
by-passing transmembrane AtP synthase, thereby dis-
rupting AtP formation.17,41,42 the intracellular dissocia-
tion of acetic acid also reduces the pH of the cytoplasm, 
which in turn leads to protein unfolding with subsequent 
membrane and DNA damage.17,42 Furthermore, the ace-
tate released during acetic acid dissociation, induces 
osmotic stress to the cell. the extent of this effect is 
known to be anion-specific but the mechanism of action 
has not been fully described. It is known that different 
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Fig. 4
Box plot of biofilm S. aureus CFu/ml detected following a 24-hour exposure to acetic acid. Dashed line represents a 99.9% reduction. solid line represents 
detection limit of assay.
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weak acids at the same pH can have very different cyto-
toxic effects.17,39,41 Bjarnsholt et al18 observed that the 
maximal antibacterial effect of acetic acid was at pH 
4.76, which was also the dissociation equilibrium point 
of acetic acid. thus, it was recommended that the pH of 
the solution be kept at this level or lower to maximize 
availability of the non-dissociated acetic acid and its anti-
bacterial effect.18 this may limit its effectiveness as 
debridement adjunct in vivo. the pH of blood and syno-
vial fluid has previously been shown to be 7.38 (stand-
ard error of the mean (sem) 0.013) and 7.77 (sem 0.04), 
respectively.43 the pH of synovial fluid is mildly reduced 
in the presence of trauma (pH 7.56 sem 0.03) and degen-
eration (pH 7.38 sem 0.01) but within the surgical site 
the equilibrium point would be driven unfavourably 
towards the dissociated form of acetic acid,18 limiting its 
effectiveness.
our study is the first in vitro evaluation of acetic acid 
against bacterial biofilms in the context of PJIs. the treat-
ment times, of 180 minutes19 and 24 hours,18 used in 
previous studies are not relevant to the evaluation of ace-
tic acid as a debridement adjunct in PJIs, nor is the in vitro 
estimation of the MIC of acetic acid using planktonic cul-
tures of clinical isolates.13 the dissolving bead biofilm 
model used in this study has been shown to reproducibly 
form staphylococcal biofilms on the substrate surface 
and reliably quantify biofilm eradication.28 our study was 
limited by the fact that acetic acid was only evaluated 
against MssA biofilms. However, from national surveil-
lance data it has been found that for the majority of PJIs 
staphylococci are implicated. For mono-microbial PJIs, 
which amount to around 75%, 30% to 38% were attrib-
uted to MssA, 4% to 5% MRsA, and 25% to 28% 
coagulase- negative staphylococci.9 In poly-microbial 
cases, gram-positive organisms were implicated in 70% 
to 80%.9 Areas of future research should include further 
evaluation of the antibiofilm effect of acetic acid using 
other clinically relevant bacterial species, further elucida-
tion of the antibiofilm mechanism of acetic acid and other 
weak acids, and the clinical evaluation of 5% acetic acid 
including the safety profile, patient tolerance, and surgi-
cal outcome when used in PJIs.
In conclusion, this study found that the MBEC of acetic 
acid following a ten- or 20-minute treatment time 
exceeded its safety threshold, making these concentra-
tions unsuitable as a topical debridement adjunct. 
However, a clinically acceptable concentration (5%) was 
still found to eliminate 96.1% of biofilm-associated MssA 
following a 20-minute treatment.
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